Gene Name |
interleukin enhancer binding factor 3, 90kDa |
heterogeneous nuclear ribonucleoprotein H2 (H) |
Image |
|
|
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
|
|
Protein-Protein Interactions |
26 interactors:
DHX9
EIF2AK2
ERG
FUS
GDF9
HNRNPH2
IL7R
KRTAP4-12
LNX1
MAGEA11
MDFI
NDRG1
PLSCR1
PRMT1
RBM5
RBPMS
RNF113A
SF1
SF3B4
SMN1
SNRPC
TRIP6
XAB2
XPO5
ZNF346
ZNF830
|
20 interactors:
DDX5
GNB2L1
HNRNPA0
HNRNPUL1
ILF3
MSI2
PQBP1
PRMT6
PRPF31
PRPF8
QKI
RAD21
RBFOX2
RBM10
RBM39
RBM4
SF1
SNRPC
TEKT1
WDR83
|
Entrez ID |
3609 |
3188 |
HPRD ID |
04420 |
03022 |
Ensembl ID |
ENSG00000129351
|
ENSG00000126945
|
Uniprot IDs |
Q12906
|
P55795
|
PDB IDs |
2L33
3P1X
|
1WEZ
1WG5
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
acting
analogues
axis
cll
cytotoxicity
dca
dichloroacetate
emphasize
exhibits
harboring
hl
indeed
invariably
knocking
leukemic
lymphocytic
maver
mec
mediating
merits
options
p21
p53mutated
p53null
p53wild
proteomic
purine
sirnas
underscored
|
|
Tagcloud (Difference) ? |
acting
analogues
axis
cll
cytotoxicity
dca
dichloroacetate
emphasize
exhibits
harboring
hl
indeed
invariably
knocking
leukemic
lymphocytic
maver
mec
mediating
merits
options
p21
p53mutated
p53null
p53wild
proteomic
purine
sirnas
underscored
|
|
Tagcloud (Intersection) ? |
|